Skip to main content

UBS Group AG

Position in ALLO — Allogene Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in ALLO

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$3,913,978
+$2,010,237 QoQ
Shares Held
1,604,090
+15.4% QoQ
Ownership
0.465%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 93% Shared 0% None 7%

Common Shares in ALLO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS Group AG holds $8,296,725,913 across 562 Biotechnology names. ALLO ranks #163 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ALLO

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,913,978 1,604,090
2025-12-31 $1,903,741 1,389,593
2025-09-30 $4,428,234 3,571,157
2025-06-30 $2,303,977 2,038,919
2025-03-31 $3,128,939 2,143,110
2024-12-31 $1,696,524 796,491
2024-09-30 $972,551 347,340
2024-06-30 $699,747 300,321
2024-03-31 $2,320,828 519,201
2023-12-31 $581,635 181,195
2023-09-30 $655,424 206,759
2023-06-30 $1,476,148 297,012
2023-03-31 $1,148,603 232,511
2022-12-31 $854,683 135,880
2022-09-30 $1,959,940 181,476
2022-06-30 $1,564,866 137,269
2022-03-31 $2,030,317 222,867
2021-12-31 $2,353,495 157,741
2021-09-30 $4,433,506 172,510
2021-06-30 $1,000,141 38,349
2021-03-31 $3,027,256 85,758
2020-12-31 $31,373 1,243
2020-09-30 $54,377 1,442
2020-06-30 $127,559 2,979
2020-03-31 $61,293 3,153